Treace John T. 4

What Happened
John T. Treace, CEO of Treace Medical Concepts, Inc. (TMCI), disposed of a total of 7,083 shares as tax-withholding related to equity awards. The filings show: 2,062 shares disposed on 2026-03-08 and 5,021 shares disposed on 2026-03-10, each at $0.00 per share (indicating shares were surrendered/withheld to satisfy tax obligations rather than sold for cash).

Key Details

• Transaction type: Code F — payment of exercise price or tax liability (shares withheld to cover taxes).
• Dates and amounts: 2026-03-08 — 2,062 shares; 2026-03-10 — 5,021 shares. Reported value $0.00 per share (no cash received).
• Filing: Form 4 filed 2026-03-11 (filed within the normal reporting window).
• Footnotes: the filing references large restricted stock unit balances (563,403 RSUs and 542,784 RSUs are cited in footnotes). The reporting person disclaims beneficial ownership of shares held by his wife or certain trusts for which spouse or he serves as trustee (per footnotes).

Context
These transactions are routine tax-withholding actions tied to equity awards (restricted stock units or similar) and are not open-market sales that would indicate cashing out. For retail investors, tax-withholding disposals are common after vesting and do not necessarily signal a change in the insider’s view of the company.